OVERVIEW In 2017, the National Academies of Science, Engineering & Medicine released a comprehensive report, “The Health Effects of Cannabis & Cannabinoids”, based on the research that had been done to date. Following that valuable report, we’ve been providing weekly Condition Reports on 2018 research for each of the conditions cited in that report, such as […]
N-Arachidonoyl dopamine (NADA) is an endogenous cannabinoid that acts as a potent agonist to the body’s CB1 and TRPV1 receptors. NADA was one of the later discovered endocannabinoids, along with 2-AGE and virhodamine. NADA was first proposed as an endocannabinoid in 2000 by T. Bisogno, D. Melck, Bobrov MYu, N. M. Gretskaya, V. V. Bezuglov, […]
OVERVIEW In 2017, the National Academies of Science, Engineering & Medicine released a comprehensive report, “The Health Effects of Cannabis & Cannabinoids”, based on the research that had been done to date. Following that valuable report, we’ve been providing weekly Condition Reports on 2018 research for each of the conditions cited in that report, such as […]
Dr. Cristina Sanchez, a molecular biologist at Compultense University in Madrid, Spain, is working to uncover whether or not cannabinoids are useful tools for fighting cancer — not just by combating the negative side effects of chemotherapy, but also by exhibiting actual anti-tumor activity. She notes that, in her and her team’s pre-clinical studies with […]
2-Arachidonyl glyceryl ether, often referred to as noladin ether or 2-AGE, is a stable analog of the endogenous cannabinoid 2-AG. It was discovered in 2000 by Lumír Hanuš and his colleagues (Saleh Abu-Lafi, Ester Fride, Aviva Breuer, Zvi Vogel, Deborah E. Shalev, Irina Kustanovich, and Raphael Mechoulam) at the Hebrew University of Jerusalem, in Israel. […]
OVERVIEW In 2017, the National Academies of Science, Engineering & Medicine released a comprehensive report, “The Health Effects of Cannabis & Cannabinoids”, based on the research that had been done to date. Following that valuable report, we’ve been providing weekly Condition Reports on 2018 research for each of the conditions cited in that report, such as […]
OVERVIEW In 2017, the National Academies of Science, Engineering & Medicine released a comprehensive report, “The Health Effects of Cannabis & Cannabinoids”, based on the research that had been done to date. Following that valuable report, we’ve been providing weekly Condition Reports on 2018 research for each of the conditions cited in that report, such as […]
2-Arachidonoylglycerol (2-AG) is an endogenous cannabinoid – one of many naturally occurring cannabinoids produced by the mammalian body (2-AG has even been found in cow’s milk and human breast milk.) 2-AG was the second endocannabinoid to be discovered, after anandamide; similarly, it is probably the second most studied endocannabinoid following anandamide. Although researchers from Teikyo […]
OVERVIEW In 2017, the National Academies of Science, Engineering & Medicine released a comprehensive report, “The Health Effects of Cannabis & Cannabinoids”, based on the research that had been done to date. Following that valuable report, we’ve been providing weekly Condition Reports on 2018 research for each of the conditions cited in that report, such as […]
Bridget Conry discusses bioavailability, broadly defined as the how and why a drug affects our body. As an herbalist, she touches on the best ways to reset our system and improve its bioavailability for substances such as cannabis. Session 3 Notes: Bioavailability Priming the body to receive information through diet, herbs, and exercise. The human […]